Osteoarthritis Trial, Recruiting NCT03168802 Sponsor: Taipei Medical University Hospital Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT03168802
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 20 and 79 years old, both men and women
  • People who have been diagnosed with lumbar vertebral facet joint syndrome (a condition causing lower back pain related to small joints in the spine)
  • People who have had lower back pain for at least six months, rated 4 or higher on a pain scale
  • People who have previously tried conventional pain treatments such as anti-inflammatory medications, opioids, muscle relaxants, oral steroids, physical therapy, or chiropractic therapy
  • People whose spine imaging shows arthritis in the facet joints (small joints in the lower back)
  • People whose referred pain (pain that spreads from the back) does not go below the knee
  • People who have had at least one diagnostic nerve block injection (a small injection of local anaesthetic near the nerves of the back) that reduced their pain by more than 75%

Who may not be able to join:

  • People whose MRI, CT scan, or physical examination shows nerve root problems in the lower back, including leg pain caused by a compressed nerve
  • People who have muscle weakness or any other condition that doctors have identified as requiring surgery
  • People who have had MRI-guided focused ultrasound (MRgFUS) or radiofrequency (RF) treatment for lower back pain in the past six months
  • People who have had previous lower back surgery
  • People who are pregnant
  • People who have an active cancer diagnosis
  • People who have known allergies to contrast dyes, local anaesthetics, or sedation medications
  • People who have a medical reason they cannot have an MRI scan (confirm with trial site)
  • People who have an acute (sudden or short-term) serious illness, such as pneumonia or blood infection, that may prevent them from completing the study
  • People with unstable heart conditions, including: unstable chest pain (angina) despite medication; a heart attack within the past 40 days; severe heart failure; uncontrolled or untreated irregular heartbeat or use of medications for heart rhythm problems; or a pacemaker
  • People who have had a severe stroke within the past six months
  • People with severely high blood pressure (lower blood pressure reading above 100 even while on medication)
  • People with an active infection or serious uncontrolled blood, neurological, or other medical conditions
  • People who are unable to communicate with the research team
  • People who are unable or unwilling to remain still for approximately two hours during the treatment procedure
  • People with blood clotting disorders or bleeding conditions, or those who have taken blood-thinning or anti-clotting medications within five days before treatment
  • People whose diagnostic nerve block injection did not reduce pain by at least 75%

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yen Yun, PhD, Taipei Medical University

Phone: 227372181

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Taipei Medical University Hospital
Registry
ClinicalTrials.gov
Start date
24 August 2018
Est. completion
25 November 2025

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Pain score change: Numerical Rating Scale (NRS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov